XLO (Xilio Therapeutics, Inc. Common Stock) Stock Analysis - Community
Xilio Therapeutics, Inc. Common Stock (XLO) is a publicly traded Healthcare sector company. As of May 21, 2026, XLO trades at $8.44 with a market cap of $48.76M and a P/E ratio of -1.97. XLO moved +1.83% today. Year to date, XLO is -10.87%; over the trailing twelve months it is -32.88%. Its 52-week range spans $6.47 to $23.80. Rallies surfaces XLO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
How does the Rallies community trade XLO?
Rallies community data for XLO shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Shannon James Samuel bought 5.00K (~$43.95K) on Mar 26, 2026.
Brennan Kevin M. sold 1.83K (~$1.17K) on Jan 2, 2026.
Frankenfield Christopher James sold 7.03K (~$4.52K) on Jan 2, 2026.
XLO Analyst Consensus
XLO analyst coverage data. Average price target: $0.00.
Common questions about XLO
How does the Rallies community trade XLO?
Rallies community data for XLO shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for XLO?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for XLO when enough community data is available.
Is XLO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for XLO. It does not provide personalized investment advice.